New ADT study from Hong Kong (1).
"A total of 4920 patients were included, consisting of 2578 statin users and 2342 non-users (mean age 76.1 ± 8.2 years). Over a mean follow-up period of 4.2 ± 3.3 years, it was observed that statin users had significantly lower risks of both PCa-related mortality (weighted hazard ratio [wHR] 0.56 ...and all-cause mortality (wHR 0.57 ...), regardless of the type of ADT used.
... Notably, these associations were more pronounced among patients with less advanced PCa, as indicated by the absence of androgen receptor antagonist or chemotherapy usage"
imo the direct effects of statins on PCa cells are:
i) a reduction in the VLDL-cholesterol available for uptake, & ...
ii) inhibition of cholesterol generation within the cells.
-Patrick